This content is machine translated Type 2 diabetes Updated SGED treatment recommendations published In recent years, the therapeutic landscape for type 2 diabetes has changed significantly. Because GLP-1 receptor agonists and SGLT-2 inhibitors have shown direct effects on cardiorenal protection in cardiovascular endpoint…
